
Medicine and Health
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
H. Ma, X. Zhang, et al.
This groundbreaking research conducted by Huan Ma, Xinghai Zhang, and colleagues unveils a bispecific nanobody that shows remarkable potency against the latest SARS-CoV-2 variants, providing hope for effective therapies against Omicron. With promising results from animal studies, the future looks bright for preventing COVID-19 infections.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.